Patent 11628181 was granted and assigned to Emory University on April, 2023 by the United States Patent and Trademark Office.
This disclosure relates to N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment and prophylaxis of viral infections.